Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning — Stella

Recruiting

Back to Schizophrenia trials

Trial locations(1 site)

United States

Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven, Connecticut

Key details

Sponsor

Yale University

Collaborators

National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH)

Enrollment target

~100 participants

Started

July 2010

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 55 Years

Sex

Male only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov